Drug Profile
Cancer vaccine NY-ESO-1 - PowderMed
Latest Information Update: 10 Oct 2021
Price :
$50
*
At a glance
- Originator PowderMed
- Class Cancer vaccines; Peptide vaccines; Peptides; Saponins
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Non-small cell lung cancer